The role of Cytokeratins as additional marker in breast carcinoma

Journal Title: Medpulse International Journal of Pathology - Year 2019, Vol 10, Issue 2

Abstract

Background:In recent years, breast carcinomas have been categorized into subtypes depending on their gene signatures. Using immunohistochemistry (IHC) it is possible to assign tumors to various molecular subtypes which can be a useful surrogate of gene expression analysis and has a wider application. Cytokeratins (CK) are used as differentiation markers in breast cancer since their expression remains stable during carcinogenesis. In breast ducts CK 7and 18 are expressed in the luminal layer, whereas CK 5/6 and 14 characterize the basal layer.Objectives: To determine the frequency of expression of each cytokeratin subtype and its correlation with age, histologic grade, lymph node status andestrogen (ER),progesterone(PR) and Her-2/neu receptor status in breast carcinoma.Materials and Methods:A 12 month prospective study was conducted on 55 cases of modified radical mastectomy specimens in the department of pathology of our institute. All the cases were subjected to routine histopathology and IHC.In each case all relevant clinicopathological data were recorded andanalyzed.Results: We were able to subtype the cases into four distinct phenotypic categories- pure luminal 25(45.46%), pure basal 2 (3.64%), basoluminal 25(45.46%) and null 3(5.45%). There was a significant correlation between histologic grade and ER/PR/Her-2/neu expression among four subtypes. A significant association was found between higher histologic grade, ER/PR negativity, Her-2/neu overexpression and basal/basoluminal phenotype.Conclusion:Addition of cytokeratins to the battery of IHC markers has helped to categorize into distinct subtypes, requiring different therapeutic approaches for improving disease free survival

Authors and Affiliations

Geethamala K, Srinivasa Murthy

Keywords

Related Articles

A histopathological study of spectrum of gastrointestinal tract lesions: Two year study

Background: Gastrointestinal tract (GIT) is an important site for wide variety of lesions which include congenital, inflammatory and neoplastic conditions. H. Pylori has been implicated in varied range of gastric lesions...

Morphology and hormone receptor status in carcinoma breast following neoadjuvant chemotherapy: A descriptive study

Background: Neoadjuvant chemotherapy in carcinoma breast followed by surgical resection presents the pathologist with the responsibility of commenting both on the diagnosis of the residual tumour, if present, and also on...

Cytological diagnosis of parasites: A tertiary care hospital experience

Parasitic infestation is a serious health problem in developing countries. Some parasitic infestations do not present with any other symptoms except single or multiple superficial palpable nodules. Fine needle aspiration...

Pseudoepitheliomatous Hyperplasia of Oral Cavity - An Enigma

Background: Pseudoepitheliomatous hyperplasia is a histopathological reaction pattern rather than a disease. It represents an extreme degree of acanthosis which histologically mimics squamous cell carcinoma especially in...

Evaluation of concordance between the cytological grading and histomorphological grading of breast carcinoma in a series of 100 cases

Background: Breast cancer survival is linked to early detection with timely appropriate treatment. Fine needle aspiration cytology is a reliable method for the initial evaluation and diagnosis of alpable masses of the br...

Download PDF file
  • EP ID EP615182
  • DOI 10.26611/10510214
  • Views 101
  • Downloads 0

How To Cite

Geethamala K, Srinivasa Murthy (2019). The role of Cytokeratins as additional marker in breast carcinoma. Medpulse International Journal of Pathology, 10(2), 129-135. https://europub.co.uk/articles/-A-615182